<DOC>
	<DOCNO>NCT00034762</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety risperidone compare placebo treatment psychotic symptom patient Alzheimer 's disease</brief_summary>
	<brief_title>Efficacy Safety Risperidone Compared With Placebo Treatment Psychotic Symptoms Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>Dementia frequently observe elderly , often associate psychotic symptom delusion hallucination , behavioral disturbance aggressive behavior , wander , aimless behavior induce psychotic symptom . This double-blind , placebo-controlled study effectiveness safety risperidone ( take twice daily 8 week ) treatment psychotic symptom patient Alzheimer 's disease . Assessments effectiveness include : Behavioral Pathology Alzheimer 's Disease ( BEHAVE-AD ) , scale use global assessment symptom associate dementia ; Psychosis Cluster Scale BEHAVE-AD , subscale ass paranoid delusional ideation well hallucination ; Clinical Global Impression-Change ( CGI-C ) , measure improve aggravated condition . Safety evaluation include incidence adverse event throughout study ; physical examination , electrocardiogram ( ECGs ) , laboratory test ( hematology , biochemistry , urinalysis ) , assessment extrapyramidal symptom specify interval . The study hypothesis treatment risperidone show great improvement psychotic symptom , measure BEHAVE-AD psychotic cluster score , patient Alzheimer 's disease , compare placebo . In addition , hypothesize risperidone well tolerate . Risperidone tablet ( 0.25 mg 0.50 mg ) placebo tablet take orally twice daily . Total daily dosage 0.5mg Day 1 , 1.0mg Days 3-5 , 1.5mg ( maximum dose ) Days 5-13 . Optimum dose maintain Weeks 3-8 treatment.Dose may increase decreased investigator 's discretion .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>A diagnosis dementia Alzheimer 's type without vascular component , score 2 item BEHAVEAD psychosis subscale screening , MiniMental State Examination ( MMSE ) score 5 23 Residents nurse home longterm care facility deem need treatment atypical antipsychotic medication . Disease could significantly diminish cognitive function history neuroleptic malignant syndrome hypersensitivity risperidone .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>psychosis</keyword>
	<keyword>elderly</keyword>
	<keyword>dementia</keyword>
	<keyword>risperidone</keyword>
	<keyword>antipsychotic agent</keyword>
</DOC>